Zacks: Clinigen Group Plc (CLIGF) Receives Average Rating of “Strong Buy” from Brokerages

Clinigen Group Plc (NASDAQ:CLIGF) has earned a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.

Zacks has also assigned Clinigen Group Plc an industry rank of 94 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research cut shares of Clinigen Group Plc from a “buy” rating to a “hold” rating in a research report on Tuesday, August 29th.

Shares of Clinigen Group Plc (NASDAQ CLIGF) opened at 13.90 on Tuesday. The stock has a market cap of $1.60 billion and a PE ratio of 330.95. Clinigen Group Plc has a 52-week low of $8.70 and a 52-week high of $13.90.

WARNING: “Zacks: Clinigen Group Plc (CLIGF) Receives Average Rating of “Strong Buy” from Brokerages” was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this news story can be accessed at https://ledgergazette.com/2017/10/19/zacks-clinigen-group-plc-cligf-receives-average-rating-of-strong-buy-from-brokerages.html.

Get a free copy of the Zacks research report on Clinigen Group Plc (CLIGF)

For more information about research offerings from Zacks Inves

Zacks has also assigned Clinigen Group Plc an industry rank of 94 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research cut shares of Clinigen Group Plc from a “buy” rating to a “hold” rating in a research report on Tuesday, August 29th.

Shares of Clinigen Group Plc (NASDAQ CLIGF) opened at 13.90 on Tuesday. The stock has a market cap of $1.60 billion and a PE ratio of 330.95. Clinigen Group Plc has a 52-week low of $8.70 and a 52-week high of $13.90.

WARNING: “Zacks: Clinigen Group Plc (CLIGF) Receives Average Rating of “Strong Buy” from Brokerages” was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this news story can be accessed at https://ledgergazette.com/2017/10/19/zacks-clinigen-group-plc-cligf-receives-average-rating-of-strong-buy-from-brokerages.html.

Get a free copy of the Zacks research report on Clinigen Group Plc (CLIGF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Clinigen Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply